Staphylococcus aureus bacteremia and cardiac implantable electronic devices in a county hospital setting: a population-based retrospective cohort study

  • Sara Pichtchoulin Department of Clinical Physiology, Västmanland County Hospital, Västerås, Sweden
  • Ingrid Selmeryd Department of Infectious Diseases, Västmanland County Hospital, Västerås, Sweden
  • Elisabeth Freyhult Department of Microbiology, Västmanland County Hospital, Västerås, Sweden
  • Pär Hedberg Department of Clinical Physiology, Västmanland County Hospital, Västerås, Sweden; and Centre for Clinical Research, Uppsala University, Västmanland County Hospital, Västerås, Sweden
  • Jonas Selmeryd Department of Clinical Physiology, Västmanland County Hospital, Västerås, Sweden; and Centre for Clinical Research, Uppsala University, Västmanland County Hospital, Västerås, Sweden
Keywords: Staphylococcus aureus, cardiac implantable electronic device, endocarditis, pacemaker


Background: Due to a high incidence of cardiac implantable electronic device-associated infective endocarditis (CIED-IE) in cases of Staphylococcus aureus bacteremia (SAB) and high mortality with conservative management, guidelines advocate device removal in all subjects with SAB. We aimed to investigate the clinical course of SAB in patients with a CIED (SAB+CIED) in a Swedish county hospital setting and relate it to guideline recommendations.

Methods: All CIED carriers with SAB, excluding clinical pocket infections, in the County of Västmanland during 2010–2017 were reviewed retrospectively.

Results: There were 61 cases of SAB+CIED during the study period, and CIED-IE was diagnosed in 13/61 (21%) cases. In-hospital death occurred in 19/61 (31%) cases, 34/61 (56%) cases were discharged with CIED device retained, and 8/61 (13%) cases were discharged after device removal. Subjects dying during hospitalization were elderly and diseased. No events was seen if the CIED was removed. Among four discharged cases with conservatively managed CIED-IE one relapse occured. Among 30 cases discharged with retained CIED and no evidence of IE, 22/30 (73%) cases had an uneventful follow-up, whereas adverse events secondary to overlooked CIED-IE were likely in 1/30 (3%) cases and could not be definitely excluded in additionally 4/30 (13%) cases.

Conclusions: During the study period, management became more active and prognosis improved. The heterogeneity within the population of SAB+CIED suggests that a management strategy based on an individual risk/benefit analysis could be an alternative to mandatory device removal.


Download data is not yet available.


  1. Bradshaw PJ, Stobie P, Knuiman MW, Briffa TG, Hobbs MST. Trends in the incidence and prevalence of cardiac pacemaker insertions in an ageing population. Open Hear. 2014;1 :e000177. doi: 10.1136/openhrt-2014-000177

  2. Chamis AL, Peterson GE, Cabell CH, Corey GR, Sorrentino RA, Greenfield RA, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001;104:1029–33. doi: 10.1161/hc3401.095097

  3. Uslan DZ, Dowsley TF, Sohail MR, Hayes DL, Friedman PA, Wilson WR, et al. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol 2010;33:407–13. doi: 10.1111/j.1540-8159.2009.02565.x

  4. Sohail MR, Palraj BR, Khalid S, Uslan DZ, Al-Saffar F, Friedman PA, et al. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol 2015;8:137–44. doi: 10.1161/CIRCEP.114.002199

  5. Snygg-Martin U, Ruus C, Skovbjerg S, Studahl M, Andersson L-M. Does extraction of cardiac implantable electronic devices improve outcome in patients with Staphylococcus aureus bacteraemia? Infect Dis (London, England) 2020;52:877–82. doi: 10.1080/23744235.2020.1799070

  6. Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), th. Eur J Cardiothorac Surg 2020;57:e1–31. doi: 10.1093/ejcts/ezz296

  7. Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Hear Rhythm 2017;14:e503–51. doi: 10.1016/j.hrthm.2017.09.001

  8. Berge A, Ekdahl C, Ekspong L, Julander I, Kurland S, Olaison L, et al. [Infectious endocarditis – national treatment guidlines from the Swedish Infectious Diseases Association] 2016. (accessed January 28, 2021).

  9. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015;36:3075–128. doi: 10.1093/eurheartj/ehv319.

  10. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633–8. doi: 10.1086/313753

  11. Tan EM, DeSimone DC, Sohail MR, Baddour LM, Wilson WR, Steckelberg JM, et al. Outcomes in Patients With Cardiovascular Implantable Electronic Device Infection Managed With Chronic Antibiotic Suppression. Clin Infect Dis 2017;64:1516–21. doi: 10.1093/cid/cix181

  12. Gadler F, Valzania C, Linde C. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry. Europace 2015;17:69–77. doi: 10.1093/europace/euu233

  13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83. doi: 10.1016/0021-9681(87)90171-8

  14. Royal College of Physicians. National Early Warning Score (NEWS) 2: Standardising the assessment of acute-illness severity in the NHS. Updated report of a working party. London RCP, 2017. (accessed February 25, 2021).

  15. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137:791–7. doi: 10.7326/0003-4819-137-10-200211190-00007

  16. Hartstein AI, Mulligan ME, Morthland VH, Kwok RYY. Recurrent Staphylococcus aureus bacteremia. J Clin Microbiol 1992;30:670–4. doi: 10.1128/jcm.30.3.670-674.1992

  17. Fowler VG, Kong LK, Corey GR, Gottlieb GS, McClelland RS, Sexton DJ, et al. Recurrent Staphylococcus aureus bacteremia: Pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis 1999;179:1157–61. doi: 10.1086/314712

  18. Deen M, de Rooij M. ClusterBootstrap: An R package for the analysis of hierarchical data using generalized linear models with the cluster bootstrap. Behav Res Methods 2020;52:572–90. doi: 10.3758/s13428-019-01252-y

  19. Fu HX, Huang XM, Zhong L, Osborn MJ, Asirvatham SJ, Espinosa RE, et al. Outcomes and Complications of Lead Removal: Can We Establish a Risk Stratification Schema for a Collaborative and Effective Approach? PACE - Pacing Clin Electrophysiol 2015;38:1439–47. doi: 10.1111/pace.12736

  20. Kancharla K, Acker NG, Li Z, Samineni S, Cai C, Espinosa RE, et al. Efficacy and Safety of Transvenous Lead Extraction in the Device Laboratory and Operating Room Guided by a Novel Risk Stratification Scheme. JACC Clin Electrophysiol 2019;5:174–82. doi: 10.1016/j.jacep.2019.01.001

  21. Jacheć W, Polewczyk A, Polewczyk M, Tomasik A, Kutarski A. Transvenous Lead Extraction SAFeTY Score for Risk Stratification and Proper Patient Selection for Removal Procedures Using Mechanical Tools. J Clin Med 2020;9:361. doi: 10.3390/jcm9020361

  22. Nakajima I, Narui R, Tokutake K, Norton CA, Stevenson WG, Richardson TD, et al. Staphylococcus bacteremia without evidence of cardiac implantable electronic device infection. Hear Rhythm 2020:Online ahead of print. doi: 10.1016/j.hrthm.2020.12.011

  23. de Kraker MEA, Wolkewitz M, Davey PG, Grundmann H. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 2011;55:1598–605. doi: 10.1128/AAC.01157-10

  24. Austin ED, Sullivan SS, Macesic N, Mehta M, Miko BA, Nematollahi S, et al. Reduced mortality of Staphylococcus aureus bacteremia in a retrospective cohort study of 2139 patients: 2007–2015. Clin Infect Dis 2020;70:1666–74. doi: 10.1093/cid/ciz498

  25. Hidalgo-Tenorio C, Gálvez J, Martínez-Marcos FJ, Plata-Ciezar A, De La Torre-Lima J, López-Cortés LE, et al. Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis. BMC Infect Dis 2020;20:160. doi: 10.1186/s12879-020-4895-1

  26. Gohil SK, Cao C, Phelan M, Tjoa T, Rhee C, Platt R, et al. Impact of policies on the rise in sepsis incidence, 2000–2010. Clin Infect Dis 2016;62:695–703. doi: 10.1093/cid/civ1019

  27. Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit Care Med 2014;42:625. doi: 10.1097/CCM.0000000000000026

  28. Kaukonen K-M, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA 2014;311:1308. doi: 10.1001/jama.2014.2637

  29. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010;36:222–31. doi: 10.1007/s00134-009-1738-3

How to Cite
Pichtchoulin, S., Selmeryd, I., Freyhult, E., Hedberg, P., & Selmeryd, J. (2021). Staphylococcus aureus bacteremia and cardiac implantable electronic devices in a county hospital setting: a population-based retrospective cohort study. Upsala Journal of Medical Sciences, 126(1).
Original Articles